Director at ParkerVision (NASDAQ: PRKR) receives 370,000 stock options at $0.24

Rhea-AI Filing Summary

ParkerVision Inc. director Paul A. Rosenbaum received a stock option grant as part of his 2026 Board compensation. On January 22, 2026, he was awarded an option to purchase 370,000 shares of ParkerVision common stock at $0.24 per share, held directly. This option represents his beneficial ownership of 370,000 derivative securities after the transaction.

The option vests in two equal installments, with half vesting on July 22, 2026 and the remaining half on January 22, 2027, aligning the award with continued Board service over that period.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROSENBAUM PAUL A

(Last) (First) (Middle)

4446-1A HENDRICKS AVE SUITE 354

(Street)

JACKSONVILLE FL 32207

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PARKERVISION INC [ PRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$0.24	01/22/2026		A		370,000		(1)	01/22/2031	Common Stock	370,000	$0.24	370,000	D

Explanation of Responses:

1. Option is awarded as compensation for 2026 Board service. Option vests in two, equal bi-annual increments on July 22, 2026 and January 22, 2027.

	/s/ Paul A Rosenbaum	01/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did ParkerVision (PRKR) report in this Form 4?

The filing reports that director Paul A. Rosenbaum was granted an option to purchase 370,000 shares of ParkerVision common stock at $0.24 per share on January 22, 2026.

Who is the reporting person in the ParkerVision (PRKR) Form 4?

The reporting person is Paul A. Rosenbaum, who is identified as a director of ParkerVision Inc. and filed the Form 4 as an individual reporting person.

How many derivative securities does the ParkerVision (PRKR) director own after this transaction?

Following the reported transaction, Paul A. Rosenbaum beneficially owns 370,000 stock options relating to ParkerVision common stock, all held in direct ownership.

What are the vesting dates for the ParkerVision (PRKR) director’s stock options?

The option vests in two equal bi-annual increments, with one-half vesting on July 22, 2026 and the other half vesting on January 22, 2027, as compensation for 2026 Board service.

What is the exercise price of the ParkerVision (PRKR) stock options granted to the director?

The option granted to Paul A. Rosenbaum has an exercise price of $0.24 per share for ParkerVision common stock.

When do the ParkerVision (PRKR) director’s stock options expire?

The stock option reported in the Form 4 has an expiration date of January 22, 2031, as disclosed in the derivative securities table.